News
YS Biopharma Granted Phase I Clinical Trial License Of Therapeutic Chronic Hepatitis B Virus Vaccine
18 Apr 24
Biotech, News, General
Chinese Biotech YS Biopharma's Next-Gen Rabies Vaccine Non-Inferior To Approved Competitor
9 Apr 24
Biotech, News, Health Care, General
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
9 Apr 24
Movers
12 Health Care Stocks Moving In Thursday's Pre-Market Session
28 Mar 24
Movers
Press releases
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
19 Apr 24
Earnings, Press Releases
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
18 Apr 24
Press Releases
YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine
9 Apr 24
Press Releases
YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility
3 Apr 24
Press Releases